Best Practices for Evaluation of Bone Marrow in Nonclinical Toxicity Studies

Abstract

This manuscript is intended to provide a best practice approach to accurately and consistently assess toxicant-induced bone marrow effects of test articles. In nonclinical toxicity studies, complete blood count data in conjunction with the histological examination of the bone marrow are recommended as the foundation for assessing the effect of test articles on the hematopoietic system. This approach alone can be used successfully in many studies. However, in some situations it may be necessary to further characterize effects on the different hematopoietic lineages, either by cytological or flow cytometric evaluation of the bone marrow. Both modalities can be used successfully, and which one is selected will depend on the expertise, preference of the facility, and the nature of the change in the bone marrow. Other specialized techniques such as clonogenic assays or electron microscopy are used rarely to further characterize hematotoxicity. The indications and techniques to successfully employ histological, cytological, or flow cytometric evaluation as well as clonogenic assays and electron microscopy are reviewed.

Role of the store‐operated calcium entry protein, STIM1, in neutrophil chemotaxis and infiltration into a murine model of psoriasis‐inflamed skin

“…Bone marrow smear preparations were performed using natural‐bristle (sable) brushes, dipped in 5% bovine serum albumin PBS buffer. Marrow was collected from the exposed cavity of the mouse femur and applied to a clean glass microscope slide in 3 wavy lines (13). Cytologic evaluation was performed with Romanowsky‐stained bone marrow differential counts (500 cells).…”

The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents

“…The percentage of other bone marrow cells changed in the mice treated with PS together with UFH. However, the bone marrow morphology may reflect changes resulting from decreased body weight gain [53]. Also, we did not observe abnormalities in the thrombopoiesis.…”

Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes

“…The morphology of MDS myeloid cells were observed through Wright-Giemsa tinct bone marrow smear. It was evaluated subjectively by light microscopy at low power (10×objectives) for overall quality and distribution, and then was analyzed at high power (100×oil objectives) for differential count including PMMBM count, with all cells in each containing eld counted to maintain representative ratios of cell types [20] . All BM morphology ndings were interpreted by two experienced and quali ed clinical pathologists.…”